Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
Industry analysis examines published SURMOUNT clinical trial data, evolving FDA compounding guidance, and telehealth access ...
In a new ACT video interview, Shanthi Sivendran, MD, MSCR, MBA, senior vice president for cancer care support at the American ...
Conscious Patients Navigate GLP-1 Options After FDA Oral Semaglutide Approval — Platform Verification Methods, Compounded Medication Regulatory Status, and Third-Party Certification Signals ...
FDA approval of mitapivat signals a shift in thalassaemia care, offering the first oral option to treat chronic anaemia.
The FDA issued an RFI seeking venture capital input on a new contract model to connect portfolio companies directly with ...
A 2022 study estimates that at-home flu tests have a sensitivity of about 63% if the test is performed within 72 hours of ...
FDA approval of Vanda’s Nereus marks a rare and meaningful regulatory milestone, introducing the first new pharmacologic ...
12don MSN
Inside the FDA's vaccine uproar
Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
For most of their lives, the two women have stayed tucked away indoors, sidelined by a rare blood disorder that makes the ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback